Active, Not Recruiting
Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)
NCT05698017
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +12 more
- Locations
-
- Tel-Aviv Sourasky Medical Center (Ichilov) Tel Aviv, Israel